These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35479840)

  • 1. Community pharmacist engagement in HIV and HCV prevention: Current practices and potential for service uptake.
    Dowling-McClay K; Mathis SM; Hagemeier N
    Explor Res Clin Soc Pharm; 2021 Dec; 4():100088. PubMed ID: 35479840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacists' nonprescription syringe dispensing perceptions and behaviors: A three-state descriptive analysis.
    Hagemeier NE; Dowling-McClay K; Baladezaei M; Curtis SJ; Spence M
    Drug Alcohol Depend; 2021 Apr; 221():108597. PubMed ID: 33631542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacist attitudes and provision of harm reduction services in North Carolina: an exploratory study.
    Parry RA; Zule WA; Hurt CB; Evon DM; Rhea SK; Carpenter DM
    Harm Reduct J; 2021 Jul; 18(1):70. PubMed ID: 34238306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacists' Opinions on the Implementation of HIV and HepC Point-of-Care-Testing in a U.S. Pharmacy Chain.
    So E; Brands M; Suomala E; Ogden B; Riss J; Cernasev A; Schommer J
    Innov Pharm; 2019; 10(1):. PubMed ID: 34007531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring pharmacy service users' support for and willingness to use community pharmacist prescribing services.
    Famiyeh IM; MacKeigan L; Thompson A; Kuluski K; McCarthy LM
    Res Social Adm Pharm; 2019 May; 15(5):575-583. PubMed ID: 30100199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription drug abuse communication: A qualitative analysis of prescriber and pharmacist perceptions and behaviors.
    Hagemeier NE; Tudiver F; Brewster S; Hagy EJ; Hagaman A; Pack RP
    Res Social Adm Pharm; 2016; 12(6):937-948. PubMed ID: 26806859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonprescription syringe sales: Resistant pharmacists' attitudes and practices.
    Chiarello E
    Drug Alcohol Depend; 2016 Sep; 166():45-50. PubMed ID: 27423213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacists' role in harm reduction: a survey assessment of Kentucky community pharmacists' willingness to participate in syringe/needle exchange.
    Goodin A; Fallin-Bennett A; Green T; Freeman PR
    Harm Reduct J; 2018 Jan; 15(1):4. PubMed ID: 29370808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A qualitative study on pharmacy policies toward over-the-counter syringe sales in a rural epicenter of US drug-related epidemics.
    Fadanelli M; Cooper HLF; Freeman PR; Ballard AM; Ibragimov U; Young AM
    Harm Reduct J; 2022 Jan; 19(1):1. PubMed ID: 34996466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacist views and pharmacy capacity to deliver professional services in the United Arab Emirates.
    Alzubaidi H; Saidawi W; Mc Namara K
    Int J Clin Pharm; 2018 Oct; 40(5):1106-1115. PubMed ID: 29926256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease risk screening by pharmacists: a behavior change wheel guided qualitative analysis.
    Almansour HA; Mekonnen AB; Aloudah NM; Alhawassi TM; Mc Namara K; Chaar B; Krass I; Saini B
    Res Social Adm Pharm; 2020 Feb; 16(2):149-159. PubMed ID: 31027964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacist peer coaching in a traditional community chain pharmacy: Implementation and perceptions.
    Hake KL; Carroll JC; Somma McGivney MA; Coley KC
    J Am Pharm Assoc (2003); 2021; 61(4S):S85-S90. PubMed ID: 33781696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacist-led HIV and hepatitis C point-of-care testing and risk mitigation counseling in individuals experiencing homelessness.
    Kherghehpoush S; McKeirnan KC
    Explor Res Clin Soc Pharm; 2021 Mar; 1():100007. PubMed ID: 35479505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacist Comfort and Awareness of HIV and HCV Point-of-Care Testing in Community Settings.
    Min AC; Andres JL; Grover AB; Megherea O
    Health Promot Pract; 2020 Sep; 21(5):831-837. PubMed ID: 31257939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacist health coaching in Australian community pharmacies: What do pharmacy professionals think?
    Singh HK; Kennedy GA; Stupans I
    Health Soc Care Community; 2020 Jul; 28(4):1190-1198. PubMed ID: 32020737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacist-initiated hepatitis C virus screening in a community pharmacy to increase awareness and link to care at the medical center.
    Isho NY; Kachlic MD; Marcelo JC; Martin MT
    J Am Pharm Assoc (2003); 2017; 57(3S):S259-S264. PubMed ID: 28506379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community pharmacy teams' experiences of general practice-based pharmacists: an exploratory qualitative study.
    Karampatakis GD; Patel N; Stretch G; Ryan K
    BMC Health Serv Res; 2020 May; 20(1):431. PubMed ID: 32423485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV prevention and drug treatment services for drug misusers: a national study of community pharmacists' attitudes and their involvement in service specific training.
    Sheridan J; Strang J; Taylor C; Barber N
    Addiction; 1997 Dec; 92(12):1737-48. PubMed ID: 9581006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.